Patient-specific vascularized tumor model: Blocking monocyte recruitment with multispecific antibodies targeting CCR2 and CSF-1R患者特异性血管化肿瘤模型: 用靶向CCR2和CSF-1R的多特异性抗体阻断单核细胞募集BIOMATERIALSIF12.92025-01-011OAAI
BCA101 Is a Tumor-Targeted Bifunctional Fusion Antibody That Simultaneously Inhibits EGFR and TGFb Signaling to Durably Suppress Tumor GrowthCANCER RESEARCHIF16.62023-04-1910OAAI
BCA101, a novel tumor-targeted bifunctional fusion antibody simultaneously inhibiting EGFR and TGF-β signaling with potential for durable tumor growth inhibitionCANCER RESEARCHIF16.62023-04-040PRE